Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone therapy for men with cirrhosis and low testosterone
ACTRN12614000526673Phase 3Completed
- Sponsor
- University of Melbourne
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis and Hypoandrogenism (TD) comparing Reandron with Placebo (2 arms). Primary endpoint: Appendicular lean muscle mass. Started May 2013; status: completed.
02
Drugs
TSX-011
03
Conditions
CirrhosisHypoandrogenism (TD)
Beyond the preview
Go deeper on ACTRN12614000526673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000526673.